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ABSTRACT 
Background: Different dementia syndromes display different patterns of everyday 
functioning. This paper explored different patterns of functioning at baseline and trajectories 
of change in behavioural-variant fronto-temporal dementia (bvFTD) and Alzheimer’s disease 
(AD).  
Methods: Data from the Uniform Data Set of the National Alzheimer’s Coordinating Centre 
were employed. The Functional Assessment Questionnaire assessed functioning at up to 
seven follow-up visits. Independent t-tests assessed variations in functioning between 
syndromes at baseline. Linear mixed effect modelling explored longitudinal functional 
trajectories between syndromes.  
Results: Data from 3,351 patients (306 bvFTD; 3,045 AD) were analysed. At baseline, bvFTD 
patients performed all daily activities poorer than AD-dementia. Linear mixed models showed 
a significant effect of syndrome and time on functioning, and evidence of interaction between 
syndrome and time, with bvFTD showing a steeper decline for using the stove and travel.  
Conclusions: Findings can help in the effective care planning of everyday functioning for 
bvFTD and AD-dementia.  
Keywords: Activities of daily living, Alzheimer’s disease, frontotemporal dementia. 
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Introduction 
Increased dependency in everyday life is a hallmark of dementia1. Whilst deteriorations in 
basic and instrumental activities of daily living (bADLs/ IADLs) are common in all dementia 
syndromes, some research indicates that everyday activities deteriorate differently across 
syndromes2,3.  
Frontotemporal dementia is characterised by heightened behavioral or semantic 
difficulties, language (semantic processing for svPPA and motor speech for nfvPPA), as well 
as motor functioning4-6, and comprises a variety of syndromes, including behavioral-variant 
fronto-temporal dementia (bvFTD)7. Some research suggests that bvFTD patients experience 
greater levels of IADL impairments than Alzheimer’s disease (AD) dementia patients8, with a 
recent study showing that directly observed performance of IADLs did not vary amongst 
syndromes, but initiative and planning were more impaired in bvFTD than in AD-dementia 
based on indirect assessments9. However, there is some ambiguity in that Wicklund and 
colleagues10 reported no significant variations amongst AD-dementia and bvFTD patients in 
activities of self-care, household, employment and recreation, shopping and money, and 
travel, but instead only in communication. In light of the limited evidence comparing different 
dementia syndromes, there is a need to investigate these variations to help differentiate 
individual syndromes better from one another at the assessment stage.  
ADLs decline hierarchically, with specific activities such as dressing to deteriorate early 
on in the disease, whilst activities such as feeding deteriorate to a greater extent in the later 
stages10-12. However, IADL research has been more limited to date. Peres and colleagues13 
showed how finance management, telephoning, using transport, and managing medication 
were significantly impaired in a mixed sample of people with dementia and declined 
longitudinally over 10 years, as opposed to healthy older adults. In a recent study by Giebel 
et al.14, a larger number of IADLs was compared across mild, moderate, and severe dementia, 
although the study was not based on longitudinal data. As expected, individual activities such 
as preparing a hot meal and finance management were more impaired the more advanced 
the dementia stage. This hierarchical decline of everyday activity performance is found to be 
associated with a decline in cognition15, with literature suggesting that deficits in general16 and 
specific areas of cognition, such as executive functioning17, are linked with increased 
dependency levels. Considering different dependency levels across fronto-temporal 
dementias and AD-dementia at baseline, it is important to investigate whether these variations 
are reflected in the longitudinal decline of everyday functioning abilities across syndromes. 
Everyday activities probably deteriorate differently across dementia syndromes. Mioshi 
and Hodges18 reported different levels of ADL decline between bvFTD, semantic dementia, 
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and progressive non-fluent aphasia (PNFA) variants over 12 months. In particular, only PNFA 
patients were reported to have a significant deterioration in total ADL and total IADL 
functioning over 12 months. In two recent studies similarly focusing on FTD syndromes, 
O’Connor et al.2 reported similar levels of everyday functioning decline between semantic and 
non-fluent variant of primary progressive aphasia patients over five years, whilst in a separate 
analysis bvFTD patients were found to show faster levels of IADL decline19. These studies 
provide some important first insights, however, to existing knowledge, no study to date has 
compared individual IADL functioning across bvFTD and AD over a prolonged period of time. 
It is important to highlight the significant burden that problems with everyday activities can 
place both on the person living with dementia20,21, and on the caregiver22,23. In particular, the 
increased decline in symptomatology in bvFTD24 can have a more severe impact on caregiver 
well-being than in other syndromes. Therefore, investigating these trajectories can help 
preparing both people with dementia and caregivers better in advance. 
 The objective of this study was to explore the trajectories of everyday functioning 
between bvFTD and AD-dementia over time, by specifically focusing on individual daily 
activities and overall daily functioning. With only limited previous research on IADL functioning 
across differential diagnoses, and more specifically on trajectories of functioning decline over 
time, we aimed to investigate the levels of dependence at baseline and the performance 
trajectories over time. We hypothesised that people with bvFTD and ADD would experience 
different levels of decline over time, without specific hypotheses on which type would 
deteriorate faster. This knowledge can have important applications for clinical practice by 
potentially helping in planning effective care management for differential diagnoses, as the 
Alzheimer’s Disease International Report (2011)25 also outlines the value of early diagnosis 
for intervention planning.  
Method 
Participants 
Data were used from the United States National Alzheimer’s Coordinating Center (NACC) 
data set which collects longitudinal data from 34 Alzheimer's Disease Centers (ADCs) on 
demographic characteristics, dementia progression, and clinical diagnosis by clinicians from 
people with any cognitive status living in the community and long-term care institutions26,27. 
Written informed consents were obtained from participants at each ADC and approved by the 
ADC's Institutional Review Board (IRB). Research using the NACC database was approved 
by the University of Washington IRB. Dementia diagnoses are provided by clinicians at each 
study centre, and a diagnosis of AD-dementia was based on recommendations from the 
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National Institute on Aging – Alzheimer’s Association workgroups28. The International 
Consensus Criteria for bvFTD4 was used for a diagnosis of bvFTD. 
The NACC data set was requested on 2nd November 2012 and contained patient data 
from September 2005 to August 2012. For this study, 5000 patient cases were used, which 
had 36,456 individual visits in the extracted database. Each patient had several entries due to 
the follow-up data, so that each patient needs to be allocated an ID at first by the researchers. 
Of the 5,000 coded cases, data from people with a diagnosis of bvFTD (N=306) and AD-
dementia (N=3,043), all living in the community, were included in this analysis. The total 
eligible sample size was 3,351, and the flow diagram for selection of the baseline sample is 
shown in Figure 1. With AD-dementia being the most common dementia syndrome, more 
NACC cases had this diagnosis as opposed to bvFTD, so that the sample size of the bvFTD 
group was smaller. The NACC dataset is representative of the dementia population at large, 
and therefore contains a larger proportion of people with AD-dementia. In order to increase 
the power of our analysis, we have chosen to analyse the two groups in observational (natural) 
setting without artificially downsizing the AD group, but with adequate statistical adjustment of 
potential confounding factors to make the two groups as balanced as possible. 
 
Measures 
The Functional Activities Questionnaire (FAQ)29 measured performance on 10 IADLs (bills; 
taxes; shopping; hobbies; using kitchen appliances; meal preparation; remembering events; 
paying attention; remembering appointments; travelling), which were scored from 0 to 3 (no 
problems to dependent). The total FAQ score is generated by adding up the individual activity 
scores, resulting in a maximum score of 30 (indicating full dependence).  
General cognition was measured using the Mini-Mental State Examination (MMSE)30. 
A total of 30 can be obtained on the MMSE, with higher scores indicating improved cognition. 
MMSE is used as a tool to measure severity of cognitive impairment. Cut-off points vary by 
study31,32, but typically scores of 26 or above are considered normal, 21 to 25 are suggested 
to indicate mild cognitive impairment, from 11 to 20 moderate, and scores from 0 to 10 are 
considered as severe cognitive impairment32.  
Dementia severity was assessed using the Clinical Dementia Rating scale (CDR)33. 
CDR scores range from 0 to 3 with higher scores indicating increased severity. A score of ‘0’ 
suggests no change in everyday living abilities, patients with very mild to mild dementia usually 
score ‘0.5’ or ‘1’, respectively. A score of ‘2’ or ‘3’ is indicative of moderate and severe 
dementia, respectively.  
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Information on socio-demographics was collected at the first study visit, and included 
data on age, gender, education, ethnicity, marital status, and living situation. The NACC data 
set does not collect data on age at diagnosis, but only at NACC visit. 
Data analysis 
Data were analysed using IBM SPSS Version 25. Descriptive analysis of demographic 
characteristics were performed using summary statistics such as mean, standard deviation 
and frequency distributions. Continuous measures at baseline were compared between 
bvFTD and AD using Independent samples t-tests, and categorical measures were compared 
using Chi-square tests. Performance measure on each IADL at baseline was analysed 
individually for each dementia syndrome and compared using independent-samples t-tests.  
The longitudinal (repeated) performance measures of each IADL across dementia 
syndromes were analysed using linear mixed effect models. The linear mixed effects models 
enabled comparing the differences in overall mean of performance scores across time points 
as well as the differences in trajectories over time between the dementia syndromes. Fixed 
effects in the models included diagnosis (bvFTD, AD-dementia), time (the visit number with a 
maximum of seven visits), and the interaction between diagnosis and time. We have used visit 
number as a proxy for the time variable. As can be expected in an observational study, 
successive visits were not equally spaced, but visits were on average one year apart. The 
models included random intercepts for subject IDs to account for any correlation between the 
repeated measures within subjects. One model was built for each individual IADL and for the 
total of all IALDs (FAQTotal) comparing performance measure for bvFTD and AD-dementia. 
First, a linear mixed model as described above was built for the FAQTotal as the outcome 
measure. The same approach was used to analyse each of the individual 10 IADLs 
subsequently. The independent variables were diagnosis (categorical), time (continuous) and 
a set of potential confounders (patient age, patient gender, patient ethnicity, and years of 
education). In all models, AD-dementia syndrome was used as the reference category for the 
diagnosis variable. As is the case for most longitudinal studies, there were fewer people in 
later visits (Table 2) due to dropouts. To minimise any potential bias due to differential dropout 
rates between the groups, we identified baseline variables that were associated with the 
dropout (e.g., ethnicity) and included within the list of covariates in linear mixed model 
analyses. 
Results  
Demographics 
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Table 1 shows the demographic characteristics across dementia syndromes at baseline. 
People with bvFTD were younger (bvFTD mean age = 63 years, AD mean age = 75 years, 
independent sample t-test p-value <0.001) and slightly more educated (bvFTD mean years of 
education = 15, AD mean years of education = 14, p<0.05). The bvFTD group had on average 
higher severity levels (mean = 6.5) based on the CDR ratings than people with AD-dementia 
(mean =4.2, p<0.001). Chi-square tests showed significant differences across ethnicity 
(c2(1)=30.5, p<0.001), gender (c2(1) =40.5, p<.001), and marital status (c2(1)=48.39, p<0.001), 
with a larger proportion of people with bvFTD being male (64.7%; AD-dementia=45.6%), white 
(bvFTD=93.7%; AD-dementia=80.8%), and married (bvFTD=86.3%; AD-dementia=68.7%).  
Table 1 also shows the outcome measures on tests of cognition. Dementia severity as 
measured with the MMSE was not found to vary between people with AD-dementia and 
bvFTD. 
 Table 2 shows the number of people with assessment data at different visits for each 
patient group. Participants had a maximum of seven visits, with bvFTD patients having 
assessment data up to the 6th visit. As is the case for most longitudinal studies, there are less 
people with assessment data at higher visits. 
 
[insert here Table 1 and 2] 
 
Baseline everyday functioning profiles by syndrome 
Table 3 shows the performance measures on the 10 IADLs across AD-dementia and bvFTD 
at baseline. Managing bills (AD-dementia= 1.4 (1.3); bvFTD= 2.2 (1.1)) and assembling tax 
records (AD-dementia= 2.3 (1.0); bvFTD= 1.5 (1.3)) were the most impaired IADLs across 
both syndromes. Using kitchen appliances (AD-dementia= 1.1 (1.2); bvFTD= 0.6 (1.0)) was 
the least impaired across AD-dementia and bvFTD. Independent samples t-tests showed that 
people with bvFTD experienced greater impairments in all 10 IADLs compared to AD-
dementia patients.  
Figure 2 shows the proportion of people with bvFTD and AD-dementia who were 
impaired on each IADL at baseline. A larger proportion of bvFTD patients were impaired on 
all activities compared to those with AD-dementia. Comparing the proportion of people who 
were impaired (Figure 2) with the average severity rating (Table 3) highlights that remembering 
appointments was impaired in a larger number of people with AD-dementia than deficits with 
bills and taxes. 
[insert here Table 3 and Figure 2] 
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Trajectories of everyday function over time 
Longitudinal FAQTotal scores as well as scores on each individual IADL were analysed using 
linear mixed effect models across the four syndromes. Table 4 shows the results of the mixed 
models considering FAQTotal and the individual 10 IADLs. All mixed models controlled for the 
effects of age, gender, ethnicity, and education, to account for the differences at baseline. 
 Across all activities and FAQTotal, bvFTD patients showed significantly worse 
performance than AD-dementia patients (Bills coeff=0.82, p<0.001; Taxes=0.86, p<0.001; 
Shopping = 0.78, p<0.001; Hobbies=0.69, p<0.001; Kitchen appliances=0.58, p<0.001; Meal 
preparation=0.80, p<0.001; Events=0.58, p<.0.001; Paying attention=0.60, p<0.001; 
Remembering dates = 0.43, p<0.001; Travel=0.66, p<0.001, FAQTotal=5.57, p<0.001).  
 The regression coefficients of time (visits), which represent the gradients or slopes of 
the IADL trajectories for the reference (AD) group, were positive for the total as well as each 
individual IADL indicating that overall performance deteriorated over time. The rates of 
increase in impairment (slopes) were statistically significant for the total as well as for each 
individual IADL (Bills =0.17, p<0.001; Taxes =0.16, p<0.001; Shopping = 0.19, p<0.001; 
Hobbies =0.17, p<0.001; Kitchen appliances=0.18, p<0.001; Meal preparation=0.19, p<0.001; 
Events=0.17, p<0.001; Paying attention=0.16, p<0.001; Remembering appointments=0.17, 
p<0.001; Travel= 0.19, p<0.001; FAQTotal =1.47, p<0.001). 
We compared the IADL trajectory slopes between the dementia syndromes by 
including the interaction (cross product) term between diagnosis and time (visits). The 
coefficients of the interaction terms (displayed in Table 4) represent the difference in slopes 
of the IADL trajectories between bvFTD and AD-dementia (the reference group). These results 
showed that performance on IADLs for bvFTD patients declined at significantly faster rates 
than that of AD-dementia patients for Using the stove (0.08, p<0.01) and Travel (0.06, p<0.05). 
All other IADLs including the overall measure (FAQ total) declined similarly across AD-
dementia and bvFTD.  
We have also conducted a sub-group analysis using linear mixed model for the overall 
functional measure (FAQ total) by splitting the sample into two groups by disease severity 
(CDR ≤ 1 vs. CDR>1). The results (additional Table A1) show that among the less severe 
patients (CDR ≤ 1), bvFTD group demonstrates poorer functional outcomes at baseline 
(coef = 4.22, p-value <0.001) compared to the AD patients. Among the more severe 
patients (CDR > 1),  bvFTD group demonstrates slightly better (coef= - 0.14, but not 
statistically significant) functional outcomes than the AD patients. However, in terms 
of the rate of change of longitudinal trajectory of overall everyday functioning profile, 
the bvFTD group did not differ significantly from the AD patients within either of the 
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severity categories which is in agreement with the  main analysis (CDR ≤ 1: interaction 
coefficient = 0.05, p-value = 0.91, 95% CI -0.84 to 0.94; CDR > 1: interaction coefficient 
= -0.35, p-value = 0.36, 95% CI -1.09 to 0.40, see Additional Table A1). In summary, it 
appears that bvFTD patients demonstrate poorer functional outcomes, particularly in 
earlier stages of the disease with similar rates of change over time to AD. This is an 
interesting and important finding that provides support against the speculation that 
effects may have been driven by bvFTD patients simply being further along in their 
disease stage. 
 
 Figure 3 shows the overall (FAQ total) IADL trajectories over time (visit) for each 
dementia syndrome based on the linear mixed model analysis. Compared to AD-dementia, 
people with bvFTD showed a similar rate of increase in impairment across the seven visits, 
where data available, but starting at a higher initial level of impairment at the baseline visit.  
 
[insert here Figure 3] 
 
Discussion 
This study adds novel findings based on in-depth everyday functioning profiles and their 
longitudinal trajectories between bvFTD and AD-dementia. Previous research primarily 
focused on global performances8,16,34, or only on some activities13, whilst some research did 
not compare syndromes all together13. With everyday functioning deficits linked to higher care 
costs and increased levels of carer burden35, this study may help identify more targeted care 
management for everyday functioning for AD-dementia and bvFTD.  
Corroborating previous evidence9, bvFTD patients were found to be significantly more 
impaired than AD-dementia patients at baseline. This corroborates previous findings by Mioshi 
and colleagues8 stating that global IADL functioning is impaired to a greater extent in bvFTD 
than in AD-dementia, whilst adding further insights by showcasing the detailed levels of 
impairments for individual activities in the present study. Findings showed how bvFTD patients 
were significantly more impaired on individual tasks such as finance management and 
engaging in hobbies compared to people with AD-dementia. One potential reason for these 
variations in functional profiles both at baseline and in their rates of decline could be different 
rates and areas of cognition affected in each syndrome. Cognition has been shown to be one 
of the primary contributors to functional dependence in dementia9,36 and declines alongside 
IADL functioning15. Whilst there are other factors that can contribute to dependence, such as 
physical limitations, depression, and environmental factors37,38, cognitive profiles and 
behavioural symptomatology differ between AD-dementia and bvFTD39-41. Therefore, it is likely 
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that these variations in cognitive profiles and behavioural changes throughout the dementia 
course are primary underlying factors as to the different functional profiles in those dementia 
syndromes. Executive functioning has been particularly linked with IADL performance42, 
specifically with finance management tasks43, and is shown to deteriorate early on in 
the course of dementia. Comparing the longitudinal trajectory of executive dysfunction 
across bvFTD and AD-dementia, only disinhibition is shown to distinguish both 
syndromes, whilst most other executive functions deteriorate relatively similarly41. 
Therefore, executive function may only partially explain differences in deterioration for 
using the stove and travel in this study. However, it may be worthwhile to note that the 
behavioural dysregulation, stereotyped behaviours (e.g., rigidity), and apathy which are 
core distinguishing features of bvFTD are arguably the most functionally impairing (to 
families) but not captured on neuropsychological testing. These features are likely to 
be contributing to their early functional impairment. Future research ought to explore the 
precise relationship of individual types of cognition, including executive function, prospective 
memory, and attention, as well as the contributions of behavioural symptoms, such as apathy, 
to the successful performance of everyday activities. Considering the paucity of literature on 
these relationships44,45, this study further showcases the relevance and value of improving this 
evidence base. 
 bvFTD patients showed a faster decline in functioning only for using the stove and 
travel. Variations in these two selected activities may be the result of different cognitive or 
neural correlates compared to other daily activities, which may be subject to greater or faster 
decline in bvFTD than in AD-dementia. Literature on the cognitive and neural correlates of 
individual IADLs is still in its infancy17,46-48, and more research needs to be conducted to obtain 
a clearer picture of these potential underlying causes of faster decline in specific IADLs in 
bvFTD, as opposed to AD-dementia. Previous research has shown that bvFTD patients 
showed a faster decline than PPA-sv patients in total ADL function over a period of three 
years19, whereas no research to date had emerged comparing the speed of decline between 
bvFTD and AD-dementia. When breaking the activities down, it was basic ADL function that 
particularly showed the greater rate of decline, as opposed to IADL function19. It is important 
to consider that the longitudinal decline in this study was based on visit number as a proxy for 
the time variable. The successive visits were not equally spaced, which could have had an 
effect on the level of deterioration between visits. These variations in time space between 
visits were however present for both subgroups, so this should not have affected the 
comparison of decline rates between the subgroups.  
Findings from this study can have several implications both for clinical practice and for 
everyday care management of dementia. This study adds novel insights into the variations in 
everyday functioning profiles between AD-dementia and bvFTD, which may be helpful in 
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contributing to effective care management planning by tailoring care to the individual functional 
needs of different syndromes. For example, the knowledge that the ability to use kitchen 
appliances deteriorates faster in bvFTD patients compared to AD-dementia patients might 
suggest that care management needs to accommodate for these deficits and plan ahead. This 
is particularly important for those people with dementia who are being supported by a family 
carer. Family carers are vital in supporting their relative with dementia with daily activities, and 
provide a large proportion of care in the home environment49. Particularly, caregiver stress is 
related to increased symptomatology of the person they are caring for50, suggesting that care 
planning should not only focus in the person with dementia, but also on their family. Therefore, 
it is important to distinguish between different syndromes, but also to investigate and 
understand the decline for individual IADLs.  
 There are several limitations and strengths to this study. An important unknown is how 
the diagnoses of bvFTD and AD-dementia are differentially delayed. It is quite possible that 
bvFTD diagnoses are more difficult and thus patients are more impaired when they are seen 
in a research center compared to AD-dementia. We were unable to directly control for possible 
effects of length of disease on the comparability of the trajectories between the two groups 
due to lack of such information in the dataset. We have however adjusted all our linear mixed 
model analyses for participants’ age, which we believe, would have mitigated the potential 
effects of the length of disease to some extent. To justify this further, it may be noted that the 
average age of diagnosis of FTD is about 60, which is a full 10 years before the average 
Alzheimer patient is diagnosed (Fast Facts About Frontotemporal Degeneeration, 2011)51. 
This difference in average age at diagnosis is similar to the difference in average age of the 
participants between the bvFTD and AD groups in our study sample (bvFTD patients are on 
average 12 years younger, see Table 1). The adjustment for participants’ age should therefore 
make the two groups more balanced (comparable) in terms of the age at diagnosis as well. 
Whilst this study benefits from a very large national sample, by data having been collected 
from 34 Alzheimer’s disease research centres, the AD-dementia group was substantially 
larger than the bvFTD group. Considering the higher incidence rate of AD-dementia compared 
to bvFTD however52, it is expected to have smaller numbers in the bvFTD subgroup. With the 
aim of maximising the power of this study, all AD-dementia patients were included in the 
analysis. The pre-selection of the first 5,000 cases only of the existing Uniform dataset could 
represent a limitation, in that it may be considered as a selection bias of the data. However, 
as elaborated above, the first 5,000 cases were selected as they were deemed sufficiently 
large to ensure the statistical comparison of the dementia subgroups. A total of 27,772 
individual entries of patient visits remained (both baseline and follow-up visits), which were 
not coded and allocated an individual patient ID. One further limitation could be the informant-
reported nature of the everyday functioning abilities. These may provide potential bias in that 
12 
 
carers have been shown to differ from directly observed measures of everyday functioning53. 
Indirect reports, as opposed to directly observed performances of ADL functioning, are 
however frequently employed in ADL research23,54,55, and without directly observed ADL data 
collected as part of the NACC Uniform data set, the fact that indirect reports of functioning 
may only represent a minor limitation. 
Conclusions 
Findings from this study have implications for the effective care management of everyday 
functioning across different dementia syndromes. People with bvFTD show faster rates of 
decline for using the stove and travel compared to people with AD-dementia. Care 
management can take these variations into account at the point of diagnosis, and address 
those activities that are found to be more or earlier impaired in certain syndromes compared 
to others. With IADL and ADL dependence constituting one of the major cost factors in 
dementia56, and being one of the primary reasons for admission into a long-term care 
institution, effectively managing increased dependence for each syndrome can potentially 
have an effect on long-term care admissions. Future research should explore how these 
variations in everyday functioning can indeed be integrated in interventions and clinical 
practice.  
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Table 1. Demographic characteristics across dementia subtypes 
 bvFTD 
(N=306) 
AD 
(N=3,045) 
PwD Age, mean (sd) 63.29 (10.05) 75.46 (9.17) 
Education, mean (sd) 14.82 (3.25) 14.36 (3.79) 
PwD Gender, N( Column %) 
  Female 
  Male 
 
108 (35.3) 
198 (64.7) 
 
1,655 (54.4) 
1,390 (45.6) 
Ethnicity, N (Column %) 
  White 
  Non-White 
 
281 (93.7) 
19 (6.3) 
 
2,455 (80.8) 
583 (19.2) 
Marital Status, N (Column %) 
  Married/living as married 
  Widowed/divorced/separated/other 
 
264 (86.3) 
42 (13.7) 
 
2038 (68.7) 
1007 (31.3) 
CDR Global, N (Column %) 
   0 
   0.5 
   1 
   2 
   3 
 
8 (2.6) 
84 (27.5) 
133 (43.5) 
59 (19.3) 
22 (7.2) 
 
280 (9.2) 
1487(48.8) 
921 (30.2) 
273 (9.0) 
84 (2.8) 
CDR sum 6.49 (4.28) 4.18 (3.92) 
MMSE (Min=0, Max=30) 22.72 (6.30)  23.07 (6.09) 
AD= Alzheimer’s disease; bvFTD= behavioral variant fronto-temporal dementia; 
CDR= Cognitive Deterioration Rating; MMSE= Mini-Mental State Examination 
 
 
 
 
Table 2. Number of people with data at different assessment visits across dementia 
subtypes. 
Visit number bvFTD AD 
1 306  3045 
2 168  2058 
3 81 1370 
4 46  893 
5 26  512 
6 12  225 
7 0 59 
AD= Alzheimer’s disease; bvFTD= behavioral variant fronto-temporal dementia 
 
 
Table 3. Everyday function variations between subtypes at baseline  
 bvFTD 
(N=306) 
AD 
(N=3045) 
Independent t-tests with 95% CI 
Finance 
management 
2.2 (1.1) 1.4 (1.3) t=10.65, p<0.001 [0.61 - 0.89] 
Assembling tax 
records, business 
affairs/papers 
2.3 (1.0)  1.5 (1.3) t=12.09, p<0.001 [0.68-0.94] 
Shopping 1.7 (1.1)  1.1 (1.2) t=8.98, p<0.001 [0.50-0.78] 
Hobby 1.5 (1.2)  0.8 (1.1) t=9.63, p<0.001 [0.56 - 0.84] 
Using kitchen 
appliances 
1.1 (1.2)  0.6 (1.0) t=7.34, p<0.001 [0.40 - 0.69] 
Preparing meal 1.7 (1.2) 1.0 (1.2) t=8.81, p<0.001 [0.52-0.82] 
Keeping track of 
current events 
1.4 (1.1) 1.0 (1.1) t=6.97, p<0.001 [0.34 -0.60] 
Paying attention 1.3 (1.0) 0.7 (1.0) t=9.1, p<0.001  
[0.44-0.68] 
Remembering 
appointments 
1.8 (1.1) 1.4 (1.1) t=5.58, p<0.001 [0.24 - 0.50] 
Travelling 1.9 (1.2) 1.3 (1.3) t=7.64, p<0.001 [0.43-0.72] 
TOTAL 20.3 (10.4) 15.5 (12.2) t=7.53, p<0.001 [3.57 - 6.09] 
 
NOTE: Data are in Mean (SD), ranging from 0 (independent) to 3 (dependent); AD= Alzheimer’s 
disease; bvFTD= behavioral variant fronto-temporal dementia 
 
Table 4: Mixed effect models for the total FAQ and individual IADLs as outcomes  
AD diagnosis is the reference category. Coefficient of Visits represents the slope for the reference category (AD 
subgroup). The interaction between diagnosis and visits represents the difference in slopes between the respective group 
and the reference group (AD). All models have been adjusted for the baseline covariates ethnicity, gender, age, and 
education. 
 
 
IADL Parameter of the 
model 
Estimate (SE)   p 95% CI 
Bills Intercept 
bvFTD 
Visits  
bvFTD*Visits 
1.51 (0.21) 
0.82 (0.10) 
0.17 (0.01) 
-0.001 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.974 
(1.11, 1.91) 
(0.63, 1.01) 
(0.16, 0.19) 
(-0.06, 0.06) 
Taxes Intercept 
bvFTD 
Visits  
bvFTD*Visits 
1.73 (0.21) 
0.86 (0.10) 
0.16 (0.01) 
-0.01 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.650 
(1.32, 2.14) 
(0.67,1.05) 
(0.14, 0.17) 
(-0.07, 0.04) 
Shopping Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.51 (0.19) 
0.78 (0.09) 
0.19 (0.01) 
0.04 (0.03) 
  0.006 
< 0.001 
< 0.001 
  0.129 
(0.15, 0.88) 
(0.61, 0.96) 
(0.18, 0.20) 
(-0.01, 0.10) 
Hobbies Intercept 
bvFTD 
Visits  
bvFTD*Visits 
1.16 (0.18) 
0.69 (0.09) 
0.17 (0.01) 
0.05 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.100 
(0.81,1.51) 
(0.52, 0.87) 
(0.15, 0.18) 
(-0.01, 0.11) 
Using the stove Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.53 (0.17) 
0.58 (0.08) 
0.18 (0.01) 
0.08 (0.03) 
  0.002 
   0.001 
< 0.000 
   0.006 
(0.20,0.86) 
(0.42,0.75) 
(0.17,0.19) 
(0.02, 0.13) 
Preparing a meal Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.77 (0.20) 
0.80 (0.10) 
0.19 (0.01) 
0.04 (0.03) 
 <0.001 
 <0.001 
 <0.001 
   0.172 
(0.38,1.16) 
(0.62,0.99) 
(0.17,0.20) 
(-0.02,0.10) 
Current events Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.94 (0.17) 
0.58 (0.08) 
0.17 (0.01) 
0.01 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.640 
(0.60,1.28) 
(0.41,0.74) 
(0.16,0.19) 
(-0.04,0.07) 
Paying attention Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.71 (0.15) 
0.60 (0.08) 
0.16 (0.01) 
0.001 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.971 
(0.40,1.01) 
(0.45, 0.75) 
(0.15,0.18) 
(-0.05, 0.05) 
Remembering 
appointments 
Intercept 
bvFTD 
Visits  
bvFTD*Visits 
1.35 (0.17) 
0.43 (0.08) 
0.17 (0.01) 
0.03 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.263 
(1.01,1.69) 
(0.27, 0.59) 
(0.15, 0.18) 
(-0.02, 0.08) 
Travel Intercept 
bvFTD 
Visits  
bvFTD*Visits 
0.92 (0.19) 
0.66 (0.09) 
0.19 (0.01) 
0.06 (0.03) 
< 0.001 
< 0.001 
< 0.001 
   0.043 
(0.54,1.30) 
(0.48,0.84) 
(0.18, 0.21) 
(0.002,0.12) 
FAQ Total Intercept 
bvFTD 
Visits 
bvFTD*Visits 
15.63 (1.82) 
5.57 (0.89) 
1.47 (0.07) 
0.14 (0.30) 
< 0.001 
< 0.001 
< 0.001 
  0.643 
(12.07,19.20) 
(3.83, 7.32) 
(1.32, 1.61) 
(-0.46, 0.74) 
  
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the baseline sample selection  
NOTE: *Cases were excluded because they did not have a dementia diagnosis of bvFTD or Alzheimer’s disease. 
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 Figure 2. Everyday function profiles of different dementia subtypes at baseline  
NOTE: Percentage of patients impaired on an activity within subtype diagnosis. Impairment includes a score between 
1 and 3 on the FAQ item. 
AD= Alzheimer’s disease; bvFTD= behavioral variant fronto-temporal dementia 
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 Figure 3: Predicted overall IADL (FAQtotal) trajectories for each dementia subtype 
based on the linear mixed model analysis. The horizontal axis (visits) refers to the 
time when functional performance scores (FAQ total) were measured.   
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Additional Table 1: Linear Mixed effect models for the overall outcome (FAQ total) by 
disease severity (CDR ≤ 1 vs. CDR >1). 
 
 
 
 
 
 
 
 
AD diagnosis is the reference category. Coefficient of Visits represents the slope for the reference category (AD 
subgroup). The interaction between diagnosis and visits represents the difference in slopes between the respective 
group and the reference group (AD). All models have been adjusted for the baseline covariates ethnicity, gender, age, 
and education. 
 
 
 
 
 
 
 
 
Disease Severity Coefficient of the 
model 
Estimate (SE)   p-value 95% CI 
CDR ≤ 1 Intercept 
bvFTD 
Visits  
bvFTD*Visits 
13.34 (1.89) 
4.22 (1.07) 
1.19 (0.08) 
0.05 (0.45) 
< 0.001 
< 0.001 
< 0.001 
   0.912 
(9.62,17.05) 
(2.13, 6.31) 
(1.03, 1.35) 
(-0.84, 0.94) 
CDR >1 Intercept 
bvFTD 
Visits 
bvFTD*Visits 
26.94 (2.82) 
-0.14 (1.08) 
 0.46 (0.13) 
-0.35(0.38) 
< 0.001 
  0.898 
< 0.001 
  0.357 
(23.01,30.87) 
(-2.26, 1.99) 
(0.19, 0.72) 
(-1.09, 0.40) 
